Dongfeng Yuan

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

Wenqun Xing, Lingdi Zhao, Baoxing Liu et al. · Frontiers in Immunology · 2021 · 72 citations · Full text

Medicine, Oncology, Surgery +16

microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer

Peng Li, Wenqun Xing, Jinliang Xu et al. · Stem Cell Research & Therapy · 2019 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Wenqun Xing, Lingdi Zhao, Xiaomin Fu et al. · Journal of Thoracic Disease · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial

Yan Zheng, Guanghui Liang, Dongfeng Yuan et al. · Cancer Communications · 2024 · 41 citations · Full text

Medicine, Oncology, Surgery +14

T Cells Expanded from PD-1+ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes

Tiepeng Li, Lingdi Zhao, Yonghao Yang et al. · Cancer Research · 2021 · 40 citations · Full text

Life Sciences, Immunology, Oncology +15